Impact of G-quadruplex structures and intronic polymorphisms rs17878362 and rs1642785 on basal and ionizing radiation-induced expression of alternative p53 transcripts

Carcinogenesis

Volumn 35, Issue 12, 2014, Pages 2706-2715

  Perriaud, Laury ^a,b   Marcel, Virginie ^a,b,g   Sagne, Charlotte ^a,b,g   Favaudon, Vincent ^a,b   Guédin, Aurore ^c,d   De Rache, Aurore ^c,d   Guetta, Corinne ^a,e   Hamon, Florian ^a,e   Teulade Fichou, Marie Paule ^a,e   Hainaut, Pierre ^f,h   Mergny, Jean Louis ^c,d   Hall, Janet ^a,b  

^a INSTITUT CURIE   (France)

^b INSERM   (France)

^c INSTITUT EUROPÉEN DE CHIMIE ET BIOLOGIE   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e CNRS   (France)

^f UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^g CENTRE LÉON BÉRARD   (France)

^h UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE QUADRUPLEX; MESSENGER RNA PRECURSOR; PROTEIN P53; ISOPROTEIN; MESSENGER RNA; TP53 PROTEIN, HUMAN;

ALLELE; ARTICLE; BINDING SITE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; INTRON; IONIZING RADIATION; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; RNA SPLICING; RNA STABILITY; ADENOCARCINOMA; ALTERNATIVE RNA SPLICING; BREAST NEOPLASMS; EXON; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; PATHOLOGY; RADIATION RESPONSE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ADENOCARCINOMA; ALTERNATIVE SPLICING; BREAST NEOPLASMS; EXONS; FEMALE; G-QUADRUPLEXES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; INTRONS; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; RADIATION, IONIZING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84964698852     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu206     Document Type: Article

References (50)

1. Lipps, H.J. et al. (2009) G-quadruplex structures: in vivo evidence and function. Trends Cell Biol., 19, 414-422.
2. Huppert, J.L. et al. (2005) Prevalence of quadruplexes in the human genome. Nucleic Acids Res., 33, 2908-2916.
3. Ribeyre, C. et al. (2009) The yeast Pif1 helicase prevents genomic instability caused by G-quadruplex-forming CEB1 sequences in vivo. PLoS Genet., 5, e1000475.
4. Paeschke, K. et al. (2013) Pif1 family helicases suppress genome instability at G-quadruplex motifs. Nature, 497, 458-462.
5. Paeschke, K. et al. (2011) DNA replication through G-quadruplex motifs is promoted by the Saccharomyces cerevisiae Pif1 DNA helicase. Cell, 145, 678-691.
6. Cayrou, C. et al. (2012) Genome-scale identification of active DNA replication origins. Methods, 57, 158-164.
7. Bochman, M.L. et al. (2012) DNA secondary structures: stability and function of G-quadruplex structures. Nat. Rev. Genet., 13, 770-780.
8. Gomez, D. et al. (2004) Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. Nucleic Acids Res., 32, 371-379.
9. Marcel, V. et al. (2011) G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms. Carcinogenesis, 32, 271-278.
10. Millevoi, S. et al. (2012) G-quadruplexes in RNA biology. Wiley Interdiscip. Rev. RNA, 3, 495-507.
11. Decorsière, A. et al. (2011) Essential role for the interaction between hnRNP H/F and a G quadruplex in maintaining p53 pre-mRNA 3'-end processing and function during DNA damage. Genes Dev., 25, 220-225.
12. Beaudoin, J.D. et al. (2013) Exploring mRNA 3'-UTR G-quadruplexes: evidence of roles in both alternative polyadenylation and mRNA shortening. Nucleic Acids Res., 41, 5898-5911.
13. Agarwala, P. et al. (2013) The G-quadruplex augments translation in the 5' untranslated region of transforming growth factor ß2. Biochemistry, 52, 1528-1538.
14. Yin, Y. et al. (2002) p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat. Cell Biol., 4, 462-467.
15. Courtois, S. et al. (2002) DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53. Oncogene, 21, 6722-6728.
16. Ghosh, A. et al. (2004) Regulation of human p53 activity and cell localization by alternative splicing. Mol. Cell. Biol., 24, 7987-7997.
17. Maier, B. et al. (2004) Modulation of mammalian life span by the short isoform of p53. Genes Dev., 18, 306-319.
18. Lazar, V. et al. (1993) Simple sequence repeat polymorphism within the p53 gene. Oncogene, 8, 1703-1705.
19. Sagne, C. et al. (2013) A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects. Cell Death Dis., 4, e492.
20. Marcel, V. et al. (2009) TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis. J. Med. Genet., 46, 766-772.
21. Sagne, C. et al. (2014) Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures. Carcinogenesis, 35, 807-815.
22. Garritano, S. et al. (2010) Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect. Hum. Mutat., 31, 143-150.
23. Fernandes, T.A. et al. (2008) Evaluation of the polymorphisms in the exons 2 to 4 of the TP53 in cervical carcinoma patients from a Brazilian population. Cell. Mol. Biol. (Noisy-le-grand)., 54 (suppl), OL1025-OL1031.
24. Jha, P. et al. (2011) TP53 polymorphisms in gliomas from Indian patients: study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3. Exp. Mol. Pathol., 90, 167-172.
25. Høgdall, E.V. et al. (2003) Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study. Anticancer Res., 23, 3397-3404.
26. Savage, S.A. et al.; National Osteosarcoma Etiology study group. (2007) Germ-line genetic variation of TP53 in osteosarcoma. Pediatr. Blood Cancer, 49, 28-33.
27. Granotier, C. et al. (2005) Preferential binding of a G-quadruplex ligand to human chromosome ends. Nucleic Acids Res., 33, 4182-4190.
28. De Cian, A. et al. (2007) Highly efficient G-quadruplex recognition by bisquinolinium compounds. J. Am. Chem. Soc., 129, 1856-1857.
29. Burger, A.M. et al. (2005) The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Res., 65, 1489-1496.
30. De Cian, A. et al. (2007) Fluorescence-based melting assays for studying quadruplex ligands. Methods, 42, 183-195.
31. Mergny, J.L. et al. (1998) Following G-quartet formation by UV-spectroscopy. FEBS Lett., 435, 74-78.
32. Guédin, A. et al. (2008) Sequence effects in single-base loops for quadruplexes. Biochimie, 90, 686-696.
33. Angèle, S. et al. (2003) ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res., 63, 8717-8725.
34. Marcel, V. et al. (2012) Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity. Cell Death Differ., 19, 816-826.
35. 2.-radical induced cleavage of disulfide bonds in proteins. A gamma-ray and pulse radiolysis mechanistic investigation. Biochemistry, 29, 10978-10989.
36. Kikin, O. et al. (2006) QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res., 34(Web Server issue), W676-W682.
37. Gemignani, F. et al. (2004) A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene, 23, 1954-1956.
38. Duan, J. et al. (2013) Genome-wide survey of interindividual differences of RNA stability in human lymphoblastoid cell lines. Sci. Rep., 3, 1318.
39. König, J. et al. (2010) iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat. Struct. Mol. Biol., 17, 909-915.
40. Xiao, X. et al. (2009) Splice site strength-dependent activity and genetic buffering by poly-G runs. Nat. Struct. Mol. Biol., 16, 1094-1100.
41. Wang, E. et al. (2012) Global profiling of alternative splicing events and gene expression regulated by hnRNPH/F. PLoS One, 7, e51266.
42. Lu, Z.X. et al. (2011) Context-dependent robustness to 5' splice site polymorphisms in human populations. Hum. Mol. Genet., 20, 1084-1096.
43. Hui, J. et al. (2003) Novel functional role of CA repeats and hnRNP L in RNA stability. RNA, 9, 931-936.
44. Merle, P. et al. (2011) Telomere targeting with a new G4 ligand enhances radiation-induced killing of human glioblastoma cells. Mol. Cancer Ther., 10, 1784-1795.
45. Beaume, N. et al. (2013) Genome-wide study predicts promoter-G4 DNA motifs regulate selective functions in bacteria: radioresistance of D. radiodurans involves G4 DNA-mediated regulation. Nucleic Acids Res., 41, 76-89.
46. Marcel, V. et al. (2011) Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ., 18, 1815-1824.
47. Bellini, I. et al. (2010) DeltaN133p53 expression levels in relation to haplotypes of the TP53 internal promoter region. Hum. Mutat., 31, 456-465.
48. Grover, R. et al. (2011) Effect of mutations on the p53 IRES RNA structure: implications for de-regulation of the synthesis of p53 isoforms. RNA Biol., 8, 132-142.
49. Khan, D. et al. (2013) Effect of a natural mutation in the 5' untranslated region on the translational control of p53 mRNA. Oncogene, 32, 4148-4159.
50. Whibley, C. et al. (2009) p53 polymorphisms: cancer implications. Nat. Rev. Cancer, 9, 95-107.